Literature DB >> 16842748

Chromium and vanadate combination increases insulin-induced glucose uptake by 3T3-L1 adipocytes.

David L Brautigan1, Allison Kruszewski, Hong Wang.   

Abstract

Insulin activates signaling pathways in target tissues through the insulin receptor and Tyr phosphorylation of intracellular proteins. Vanadate mimics insulin and enhances its actions through inhibition of protein Tyr phosphatases. Chromium is a micronutrient that enhances insulin action to normalize blood glucose, but the mechanism is not understood. Here we show that either vanadate or chromium stimulates Tyr phosphorylation of insulin receptor in mouse 3T3-L1 adipocytes compared to insulin alone, but a combination of vanadate and chromium is not additive. Phosphorylation of MAPK or 4E-BP1 as markers for insulin signaling is stimulated by vanadate plus insulin, and chromium does not enhance the effects. Vanadate robustly activates glucose uptake by 3T3-L1 adipocytes even without added insulin and increases insulin-stimulated glucose uptake. Chromium pretreatment of adipocytes slightly enhances glucose uptake in response to insulin, but significantly increases glucose uptake above that induced by insulin plus vanadate. These data show that chromium enhances glucose uptake even when Tyr phosphorylation levels are elevated by vanadate plus insulin, suggesting separate mechanisms of action for vanadate and chromium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842748     DOI: 10.1016/j.bbrc.2006.06.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.

Authors:  Zhong Q Wang; William T Cefalu
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

2.  Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.

Authors:  Emily M Horvath; Lixuan Tackett; Alicia M McCarthy; Priya Raman; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2007-12-28

3.  Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizaki rats.

Authors:  Aicha Abdourahman; John G Edwards
Journal:  IUBMB Life       Date:  2008-08       Impact factor: 3.885

4.  Chromium enhances insulin responsiveness via AMPK.

Authors:  Nolan J Hoffman; Brent A Penque; Kirk M Habegger; Whitney Sealls; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  J Nutr Biochem       Date:  2014-02-20       Impact factor: 6.048

5.  Metalloradical complexes of manganese and chromium featuring an oxidatively rearranged ligand.

Authors:  Remle Celenligil-Cetin; Patrina Paraskevopoulou; Nikolia Lalioti; Yiannis Sanakis; Richard J Staples; Nigam P Rath; Pericles Stavropoulos
Journal:  Inorg Chem       Date:  2008-12-01       Impact factor: 5.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.